University of North Carolina at Chapel Hill
Chapel Hill, NC, United States
Dr. Ishizawar is focused on providing exceptional care to patients with diverse rheumatologic conditions at the UNC Hospitals Rheumatology Specialty Clinic. She is involved in medical education at the University of North Carolina as the Program Director for the Adult Rheumatology Fellowship Program. Dr. Ishizawar also participates in educational activities with the American College of Rheumatology.
Dr. Ishizawar’s research is focused on understanding mechanisms that promote autoimmunity versus tolerance in the immune system. She has formed and leads the Immuno-Oncology Group (IOG). The IOG focuses on cancer patients treated with Immune Checkpoint Inhibitor (ICI) treatment who develop Immune Related Adverse Events (irAEs) and research that utilizes this unique opportunity to understand the pathogenesis of rare autoimmune conditions. She has previously participated in functional genomic research in rheumatoid arthritis.
I have no relevant financial relationship(s) with ineligible companies to disclose.
Monday, November 14, 2022
3:00 PM – 3:45 PM Eastern Time
